Press release content from Business Wire. The AP news staff was not involved in its creation.
InClin Announces Quasar Publication Featuring First Virtual Inspection Conducted by the European Medicines Agency (EMA)
January 20, 2021 GMT
SAN MATEO, Calif. (BUSINESS WIRE) Jan 20, 2021
InClin, Inc., a full-service Contract Research Organization (CRO) with offices in the San Francisco Bay Area and Sydney, Australia, today announced the publication of a manuscript entitled: “The New Norm: A Global Virtual GCP Preapproval EMA Inspection” in Issue #154 January 2021 edition of Quasar, the Research Quality Association’s (RQA) quarterly journal.
The article describes how the European Medicines Agency (EMA) and sponsor collaborated to successfully complete a global, fully virtual, and remote EMA inspection, the first of its kind. Ultimately, a robust plan, flexibility, and innovative use of appropriate resources, logistics, and electronic tools were key components of the successful EM